NCT05066386View on ClinicalTrials.gov

Improving the Accuracy of Revised Cardiac Risk Index With HbA1C:Hemoglobin Ratio (HH Ratio)

CompletedOBSERVATIONAL
Enrollment

20,099

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

July 1, 2021

Study Completion Date

August 1, 2021

Conditions
Risk StratificationPerioperative Medicine
Interventions
OTHER

Modified RCRI risk stratification

"The objective of the study is to compare the predictive value of RCRI and substitution of the DM on insulin component with HH ratio for 30- and 90-day mortality, and postoperative acute myocardial injury(AMI) and acute kidney injury(AKI)."

All Listed Sponsors
lead

Singapore General Hospital

OTHER

NCT05066386 - Improving the Accuracy of Revised Cardiac Risk Index With HbA1C:Hemoglobin Ratio (HH Ratio) | Biotech Hunter | Biotech Hunter